title: A novel approach to establishing the design space for the oral formulation manufacturing process.
abstract: A novel approach to establishing the design space for the oral formulation manufacturing process was investigated. A response surface method incorporating multivariate spline interpolation was applied to overcome the nonlinear problem, which is always problematic in pharmaceutical development studies, and a bootstrap resampling technique, polynomial approximation technique, and 95% confidence intervals based on a nonparametric approach were applied to estimate the reliability of the established design space derived from the nonlinear response surface model. The critical quality attributes (CQAs) of intermediate material rather than the critical process parameters (CPPs) were chosen as the causal factors for the response variables, which were CQAs of the final product to avoid scale-gap and equipment-gap. This enabled the effective use of data sets accumulated during all pharmaceutical development studies. It was confirmed that a conservative border as well as an optimistic border of the design space for practical use was obtained considering the variability of the border of the design spaces on nonlinear response surfaces. Furthermore, the nonlinear response surface model using CQAs of intermediate material derived from data sets of a laboratory scale study and pilot scale studies could predict the CQA of the final product (2.5 h dissolution of commercial-scale study) with high accuracy. Consequently, the proposed novel approach overcame all of the difficulties for the manufacturing process development of oral formulations and this is the first study to demonstrate the effectiveness of the design space using CQA of intermediate material for the oral formulation manufacturing process.
authors.affiliation: Department of Pharmaceutics, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo, 142-8501, Japan. tadashi.norioka@astellas.com
authors.forename: Tadashi
authors.initials: T
authors.lastname: Norioka
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Onuki
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Andou
authors.forename: Daisuke
authors.initials: D
authors.lastname: Tsunashima
authors.forename: Kazunari
authors.initials: K
authors.lastname: Yamashita
authors.forename: Kozo
authors.initials: K
authors.lastname: Takayama
mesh_terms: D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D008956:Models, Chemical; D015233:Models, Statistical; D015999:Multivariate Analysis; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D012107:Research Design; D013607:Tablets / Q000737:chemistry
chemical_list: D004364:Pharmaceutical Preparations; D013607:Tablets